Wuxi PharmaTech To Build Largest Preclinical Drug Safety Center In China

SHANGHAI - Chinese pharmaceutical R&D outsourcing services provider WuXi PharmaTech will invest $40 million to build its first good laboratory practices center in Suzhou. The GLP center will be the largest modern drug safety evaluation center in China, the New York Stock Exchange-listed company said Oct. 9